/PGEN

Precigen Inc

PGEN

$6.85USD↑+2.54%+0.17 today

MARKET CAP

2.5B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$7 – $7

52W RANGE

$3

$8

AI Summary

Stalk

StalkMedium

PGEN remains in a Stage 2 advancing structure above the 50-day SMA, but the active Bullish Exhaustion pattern at late-August highs signals waning upside momentum. Price is pulling back into declining 9- and 20-day EMAs with RSI in a neutral range, offering a buy-on-dip setup. Medium-term bias stays bullish, while short-term timing is neutral—entries are best deferred until clear acceptance off the EMA zone.

↑Q2 revenue $55M; Papimius sales $53.1M, up 145% QoQ
↑FDA approval and 7-year orphan drug exclusivity for RRP therapy
↓Insiders sold ~235K shares (~$1.38M), flagging possible concern

Full analysis →

Buying

6

institutions

Selling

7

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	17.15 M	97.74 M	+1.92 M	+65.9%	0.00%
WP Woodline Partners LP Q2 2026	SELL	1.40 M	7.99 M	+-1.40 M	-26.3%	0.02%
PA Point72 Asset Management, L.P. Q2 2026	SELL	1.27 M	7.22 M	+-5.48 M	-72.3%	0.01%
CA Citadel Advisors LLC Q2 2026	SELL	1.05 M	5.96 M	+-1.96 M	-48.7%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	849.30 K	5.08 M	+-23.98 K	+78.9%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUYNEW	605.30 K	3.45 M	+605.30 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	145.60 K	829.92 K	+-39.39 K	+15.9%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	178.00 K	687.97 K	+89.00 K	+85.2%	0.00%
MM Millennium Management LLC Q2 2026	BUY	100.87 K	574.98 K	+41.06 K	+148.4%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	61.50 K	350.57 K	+58.81 K	+3258.6%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	32.28 K	184.01 K	+-96.69 K	-63.1%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	27.76 K	158.23 K	+27.76 K	+0.0%	0.00%
MG Man Group Plc Q2 2026	SELL	0.00	0.00	+-75.44 K	-100.0%	0.00%